The A-share innovative drug sector continued to rise, with Hansen Pharmaceutical achieving five consecutive daily limit-ups. Toujing Life, Yuhang Pharmaceutical, Huasen Pharmaceutical, Hainan Haiyao, and Xidian Pharmaceutical also hit their daily limit-ups, while Medicilon, Wanbang Pharmaceutical, and Jiankai Technology followed suit.